Invention Grant
US09562891B2 Method for screening patient-specific anti-cancer agent using limiting dilution assay
有权
使用有限稀释测定筛选患者特异性抗癌药物的方法
- Patent Title: Method for screening patient-specific anti-cancer agent using limiting dilution assay
- Patent Title (中): 使用有限稀释测定筛选患者特异性抗癌药物的方法
-
Application No.: US14228205Application Date: 2014-03-27
-
Publication No.: US09562891B2Publication Date: 2017-02-07
- Inventor: Do Hyun Nam , Kyeung Min Joo , YeonSook Choi
- Applicant: Samsung Life Public Welfare Foundation
- Applicant Address: KR Seoul
- Assignee: SAMSUNG LIFE PUBLIC WELFARE FOUNDATION
- Current Assignee: SAMSUNG LIFE PUBLIC WELFARE FOUNDATION
- Current Assignee Address: KR Seoul
- Agency: Hultquist, PLLC
- Agent Mary B. Grant
- Priority: KR10-2013-0120118 20131008
- Main IPC: G01N33/74
- IPC: G01N33/74 ; A61P35/00 ; G01N33/50
Abstract:
A screening method is described for selecting patient-specific anti-cancer agents reflecting individual genetic properties, in a precise and rapid manner, using an extremely small amount of cancer cells. Such screening method is useful for development of novel anti-cancer agents and the personalized medical field.
Public/Granted literature
- US20150101070A1 METHOD FOR SCREENING PATIENT-SPECIFIC ANTI-CANCER AGENT USING LIMITING DILUTION ASSAY Public/Granted day:2015-04-09
Information query
IPC分类:
